| 1 | Treatment failure (i.e. virological, immunological, and/or clinical failure |
| 1.1 | Virological failure |
| 1.2 | Partial virological failure |
| 1.3 | Immunological failure - CD4 drop |
| 1.4 | Clinical progression |
| 1.5 | Resistance (based on test result) |
| 10 | Hyperlactataemie/lactic acidosis |
| 11 | Bone toxicity |
| 15 | Social contra-indication |
| 16 | Contra-indication unspecified |
| 16.8 | Contra-indication expired |
| 16.9 | Contra-indication – other |
| 17 | MTCT regimen completed |
| 2 | Abnormal fat redistribution |
| 3 | Concern of cardiovascular disease |
| 3.1 | Dyslipidaemia |
| 3.2 | Cardiovascular disease |
| 4 | Hypersensitivity reaction (skin eruption etc.) |
| 5 | Toxicity, predominantly from abdomen/G-I tract |
| 5.1 | Toxicity - GI tract |
| 5.2 | Toxicity - Liver |
| 5.3 | Toxicity - Pancreas |
| 6 | Toxicity, predominantly from nervous system |
| 6.1 | Toxicity - peripheral neuropathy |
| 6.2 | Toxicity - neuropsychiatric |
| 6.3 | Toxicity - headache |
| 7 | Toxicity, predominantly from kidneys |
| 70 | Pregnancy - toxicity concerns (during pregnancy) |
| 75 | Pregnancy - switch to a more appropriate regimen for PMTCT |
| 8 | Toxicity, predominantly from endocrine system |
| 8.1 | Diabetes |
| 88 | Death |
| 9 | Haematological toxicity (anemia etc.) |
| 90 | Side effects - any of the above but unspecified |
| 90.1 | Comorbidity |
| 91 | Toxicity, not mentioned above |
| 91.1 | Toxicity, unspecified |
| 92 | Availability of more effective treatment (not specifically failure or side effect related) |
| 92.1 | Simplified treatment available |
| 92.2 | Treatment too complex |
| 92.3 | Drug interaction |
| 92.31 | Drug interaction - commencing TB/BCG treatment |
| 92.32 | Drug interaction - ended TB/BCG treatment |
| 92.33 | Change in eligibility criteria (e.g. child old enough for tablets; refrigerator no longer available) |
| 92.4 | Protocol change |
| 92.5 | Regular treatment termination (used in tblMED e.g. for DAA's against HCV, antibiotics) |
| 92.6 | End of empiric treatment |
| 92.9 | Change in treatment not due to side-effects, failure, poor adherence or contra-indication |
| 93 | Structured Treatment Interruption (STI) |
| 93.1 | Structured Treatment Interruption (STI) - at high CD4 |
| 94 | Patient's wish/decision, not specified above |
| 94.1 | Non-compliance |
| 94.2 | Defaulter |
| 95 | Physician's decision, not specified above |
| 96 | Pregnancy (see also more specific codes 70 and 75 |
| 96.1 | Pregnancy intended |
| 96.2 | Pregnancy ended |
| 97 | Study treatment |
| 97.1 | Study treatment commenced |
| 97.2 | Study treatment completed |
| 97.6 | Drug not available |
| 98 | Other causes, not specified above |
| 99 | Unknown |